Bioclinica Launches OnPoint Direct

A CTMS for the mid-market and CRO sectors 

  DOYLESTOWN, PA., May 25, 2016 -- Bioclinica, Inc., a specialty clinical trials technology and services provider, today introduced

OnPoint Direct

, a Clinical Trial Management System (CTMS) geared toward mid-market biopharma and Contract Research Organizations (CROs). OnPoint Direct offers a cost-friendly pricing structure that empowers organizations to adopt a full-featured clinical trial management solution without the complex configuration, capital investment or perpetual licensing models customary of other systems.   "We recognize that some organizations run fewer studies, so we created a purpose-built CTMS just for them," said Bioclinica's Vice President of Product Management, eHealth Solutions, Ron Burns. OnPoint Direct is a SaaS-based rapid start version of Bioclinica's

OnPoint CTMS

, which is used by large pharma companies and CROs around the globe to manage their clinical trials. "Bioclinica now provides organizations with a premier end-to-end study management tool that takes them from rapid study start-up, to study conduct, and on through to study close-out with efficiencies built into every step of the process," Burns said.   OnPoint Direct is an out-of-the-box solution that shares all of the same core functionality as the original OnPoint, but with streamlined configuration, slashing ramp-up time and investment. The SaaS-based offering is delivered through Bioclinica's secure

eHealth Cloud

, which leverages the Bioclinica Cloud Transformation Gateway™, a secure standards-based integration exchange that connects its eClinical Platform to innovative third-party applications and industry data banks.   "Organizations can now get studies up and running in a matter of weeks compared to several months," Burns said. "With OnPoint Direct we focused on workflows people are using every day, like those related to Microsoft Word, Excel, Outlook and SharePoint.  OnPoint Direct seamlessly integrates with this suite, creating a familiar and comfortable working environment." The approach reduces training time and speeds adoption.   To kick-off the new OnPoint Direct offering, Bioclinica will be conducting demonstrations in its exhibit at the

DIA Annual Meeting

to be held on June 26-30 in Philadelphia. One of Bioclinica's CTMS experts, Lynn Fraser, is participating in a panel discussion about using CTMS to facilitate collaboration.  

About Bioclinica

Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized by three business segments to deliver focused service supporting multifaceted technologies. The Medical Imaging and Biomarkers segment provides medical imaging and cardiac safety services and includes a molecular marker laboratory. The eHealth Solutions segment comprises the eClinical Solutions platform; Clinverse Financial Lifecycle Solutions; Safety and Regulatory Solutions; Strategic Consulting Services; App xChange Alliances; and eHealth Cloud Services. Under the Global Clinical Research segment, Bioclinica offers a network of research sites, patient recruitment-retention services, and a post-approval research division. The Company serves more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe and Asia. Learn more at

www.bioclinica.com

.